Fort Pitt Capital Group’s GSK GSK Stock Holding History

Fort Pitt Capital Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-4	Closed	-$259	–	107
2014 Q2	$259	Buy	+4	New	+$271	0.03%	98

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fort Pitt Capital Group's GSK Position: Q3 2014 in Review

Fort Pitt Capital Group sold out of GSK (GSK) in Q3 2014, closing a stake of 4 shares — an estimated $259 sold.

Fort Pitt Capital Group first reported a position in GSK in Q2 2014 and held it in 1 quarter. The position peaked at $259 in Q2 2014. 702 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

Fort Pitt Capital Group reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
Fort Pitt Capital Group sold 4 GSK shares in Q3 2014, an estimated $259.
Fort Pitt Capital Group first reported a position in GSK in Q2 2014 and held it in 1 quarter.
Fort Pitt Capital Group's GSK position peaked at $259 in Q2 2014.
702 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Fort Pitt Capital Group's 13F filing for Q3 2014, filed 7 Nov 2014.